Drug Database
TA
tamoxifen (tamoxifen, Douglas)
✓ ApprovedDouglas Pharmaceuticals Limited · ESR1 · Small Molecule
What is tamoxifen?
tamoxifen is a small molecule developed by Douglas Pharmaceuticals Limited. It is approved for therapeutic indications via oral (po).
Drug Profile
| Brand Names | tamoxifen, Douglas |
| Company | Douglas Pharmaceuticals Limited |
| Drug Class | Small Molecule |
| Molecular Target | ESR1 |
| Route | Oral (PO) |
| Status | Approved |
Mechanism of Action
Molecular Targets
tamoxifen acts on 1 molecular target:
| ESR1 | estrogen receptor 1 (ER, ESR) |
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.
Therapeutic Indications
tamoxifen is developed for 1 unique indication across 1 therapeutic area.
| Therapeutic Area | Condition | Phase |
|---|---|---|
| Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Breast cancer | ✓ Approved |
Related Research Articles
Unable to load articles right now.